|
| Status |
Public on Sep 04, 2017 |
| Title |
Gr. 2 = MCF7C WT Tamoxifen 2 |
| Sample type |
RNA |
| |
|
| Source name |
Breast cancer cell line
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: MCF7C
wt or y537s: WT
treatment: Tamoxifen
|
| Treatment protocol |
breast cancer cell lines
|
| Growth protocol |
NA
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Trizol extraction of total RNA was performed according to the manufacturer's instructions.
|
| Label |
biotin
|
| Label protocol |
3' IVT express
|
| |
|
| Hybridization protocol |
Standard Affymetix protocol for 3' IVT design
|
| Scan protocol |
Scanner GCS3000 7G
|
| Description |
Gr. 2 = MCF7C WT Tamoxifen
|
| Data processing |
The data were analyzed with Partek and BRB Array Tools software, RMA method for expression estimation
|
| |
|
| Submission date |
Feb 28, 2017 |
| Last update date |
Sep 04, 2017 |
| Contact name |
Suzanne Fuqua |
| Organization name |
Baylor College of Medicine
|
| Street address |
1 Baylor Plaza
|
| City |
Houston |
| State/province |
Texas |
| ZIP/Postal code |
77030 |
| Country |
USA |
| |
|
| Platform ID |
GPL570 |
| Series (1) |
| GSE95529 |
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling |
|
